Mexiletine for the Treatment of Muscle Cramps in ALS
Public ClinicalTrials.gov record NCT01811355. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT01811355
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Bjorn Oskarsson, MD
- Other
- Enrollment
- 23 participants
Conditions and interventions
Interventions
- Mexiletine Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 21 Years to 89 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2013
- Primary completion
- Feb 29, 2016
- Completion
- Apr 30, 2016
- Last update posted
- Aug 27, 2017
2013 – 2016
United States locations
- U.S. sites
- 6
- U.S. states
- 1
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCD Telehealth Network - Lake Almanor Clinic | Chester | California | 96020 | — |
| UCSD Department of Neurosciences ALS Clinical Trials (ACT) Program | La Jolla | California | 92093 | — |
| UCLA Neuromuscular Research Program | Los Angeles | California | 90095 | — |
| UCD Telehealth Network | Multiple Locations | California | Various | — |
| UC Irvine Health ALS & Neuromuscular Center | Orange | California | 92868 | — |
| UC, Davis Medical Center ALS Clinic | Sacramento | California | 95817 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01811355, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 27, 2017 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01811355 live on ClinicalTrials.gov.